Last reviewed · How we verify

NCT06780722: HEPHAISTOS

Study of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Procedure

Recruiting now Last updated 30 March 2026
What this trial tests

trial testing blood sampling in Cardiac Arrest in 50 participants. Currently enrolling.

Timeline
19 December 2025
Primary endpoint
6 June 2027
19 June 2027

Quick facts

Lead sponsorNantes University Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date19 December 2025
Primary completion6 June 2027
Estimated completion19 June 2027
Sites12 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Nantes University Hospital

Who can join

18 and older, any sex, with Cardiac Arrest or Reanimation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the level of hypoxemia during the occurrence of cardiocirculatory arrest during a Maastricht III organ donation procedure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of blood sampling

Trials testing the same drug.

Other recruiting trials for Cardiac Arrest

Currently open trials in the same condition.

Other Nantes University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06780722.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing